This paper proposes a plasma polymerization system that can be used to modify the surface of the widely used biomaterial, polyurethane (PU), by employing low-cost hexamethyldisiloxane (HMDSO) and tetrafluoromethane (CF4) as precursors; this system features a pulsed-dc power supply. Plasma-polymerized HMDSO/CF4 (pp-HC) with coexisting micro- and nanoscale morphology was obtained as a superhydrophobic coating material by controlling the HMDSO/CF4 (f(H)) monomer flow ratio. The developed surface modification technology can be applied to medical devices, because it is non-cytotoxic and has favorable hemocompatibility, and no blood clots form when the device surface direct contacts. Experimental results reveal that the obtained pp-HC films contained SiOx nanoparticles randomly dispersed on the micron-scale three-dimensional network film surface. The -CF functional group, -CF2 bonding, and SiOx were detected on the film surface. The maximal water contact angle of the pp-HC coating was 161.2 degrees, apparently attributable to the synergistic effect of the coexisting micro- and nanoscale surface morphology featuring a low surface-energy layer. The superhydrophobic and antifouling characteristics of the coating were retained even after it was rubbed 20 times with a steel wool tester. Results of in vitro cytotoxicity, fibrinogen adsorption, and platelet adhesion tests revealed favorable myoblast cell proliferation and the virtual absence of fibrinogen adsorption and platelet adhesion on the pp-HC coated specimens. These quantitative findings imply that the pp-HC coating can potentially prevent the formation of thrombi and provide an alternative means of modifying the surfaces of blood-contacting biomaterials. (C) 2015 Elsevier B.V. All rights reserved.